1) NAFLD
非酒精性脂肪肝
1.
The Expression and Role of AQP9 in Models of Cultured Steatosis Hepatocytes and the Role of p38 MAPK Signal Transduction Pathway in the Expression of AQP9 in NAFLD.;
AQP9在非酒精性脂肪肝中作用机制的研究
2.
Effect of Xiao-Yu-Hua-Tan-Yin on Hepatic Tissue Expressing UCP2 of NAFLD Rat;
消瘀化痰饮对非酒精性脂肪肝大鼠肝组织UCP2表达的影响
3.
Objective To investigate the effect of puerarin on hepatic lipid of nonalcoholic fatty Liver disease(NAFLD)rats.
目的观察葛根素对非酒精性脂肪肝大鼠模型肝脏脂质的影响。
2) NAFLD
非酒精性脂肪性肝病
1.
Influences of Aerobic Exercises on Body Mass and Liver Ultrasound Exam of NAFLD Patients;
有氧运动对非酒精性脂肪性肝病身体成分和肝脏声像图的影响
2.
Study on the Copy of NAFLD Models Through Corn Oil;
玉米油复制非酒精性脂肪性肝病动物模型的研究
3.
Objective To investigate the expression of mRNA of resistin in the livers of rats with developing non-alcoholic fatty liver disease (NAFLD) and explore the effects of resistin in pathogenesis of the model of rats with NAFLD.
目的观察非酒精性脂肪性肝病(NAFLD)模型大鼠肝脏抵抗素mRNA的动态表达,探讨抵抗素在大鼠NAFLD发病中的作用。
3) NAFLD
非酒精性脂肪肝病
1.
The Effects and Pathogenesis Research of Pioglitazone and Polyene Phosphatidylcholine Intervention in NAFLD in Rats;
卡司平、易善复干预大鼠非酒精性脂肪肝病的作用及机理研究
2.
Methods Forty-two male SD rats were randomized into 2 groups,normal control group(14 cases) and NAFLD group(28 cases).
目的探讨姜黄素治疗大鼠非酒精性脂肪肝病(NAFLD)的治疗作用。
3.
Leptin,Ghrelin and NAFLD;
非酒精性脂肪肝病(nonalcoholic fatty liver disease,NAFLD)是一种肝组织病理学改变与酒精性肝病相类似但无过量饮酒史的临床综合征。
4) NAFLD
NAFLD
1.
Experimental Study on Effect of Traditional Chinese Medicine Dialectical Treating Blood-fat Index on NAFLD Rats;
中医辨证治疗对NAFLD大鼠血脂等影响的实验研究
2.
The Studies on the Relationships between the Distributions of Abdominal Adipose Tissue, the Diversity of Adipocytokine and NAFLD;
腹部脂肪分布及脂激素表达变化与NAFLD关系的初步研究
3.
Objective: Rats models of NAFLD were established by giving a fat-riched diet.
目的:建立大鼠非酒精性脂肪性肝病(NAFLD)模型,探讨肠源性内毒素血症在NAFLD中的形成及其作用机制、血浆脂联素的水平、肝脏过氧化物酶体增值物活化受体γ(peroxisome proliferators-activated receptors gamma,PPARγ)的表达和甘氨酸对大鼠血浆脂联素的水平及肝组织PPARγ表达的影响及其相关机制,为临床防治非酒精性脂肪性肝病提供新思路。
5) NAFLD
NAFLDL
6) Nonalcoholic fatty liver disease (NAFLD)
NAFLD（非酒精性脂肪肝）
参考词条
补充资料：肝脂肪变性
肝脂肪变性
steatosis of liver
肝脏肝细胞胞浆内出现脂肪滴。脂质主要是中性脂肪。常见于缺氧、缺血、中毒、感染等因素影响肝细胞脂肪代谢平衡，出现脂质在细胞内堆积。发生脂肪变性的机制为：①脂肪合成或输入过多，如肥胖病及糖尿病；②脂肪氧化利用障碍，如中毒性肝炎；③脂蛋白形成和输出障碍，如化学性肝炎。重度脂肪变性可引起肝功能衰竭，甚至肝细胞坏死。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。